Lawmakers on the Senate Finance Committee are expected to question executives about pricing practices and other issuesRising drug prices will be in the spotlight as pharmaceutical industry executives testify before the Senate Finance Committee on Tuesday. Lawmakers are expected to question executives from firms such as Merck & Co. and Pfizer Inc. about their pricing practices and methods of thwarting competition from lower-cost generic rivals. Sen.
The price of insulin has skyrocketed over the last few decades, making it increasingly difficult for diabetics to afford. WSJ’s Jason Bellini takes a look at some of the unconventional steps Americans are taking to access the lifesaving drug.
Outrageous drug prices fuel corporate profits. Is there any doubt how the SenateGOP will conduct the meetings?
Like the tobacco CEOs, pharma bosses are making promises and claims they will come to regret as Americans crack down on those who extract massive profits from the sick.
They got a free ride & red carpet rolled out under the obama administration.
Na sala de aula
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
Blank-Check Companies, a Hot IPO Fad, Contain Pitfalls for InvestorsBlank-check companies are enjoying their highest popularity in more than a decade. But investors should still be cautious about the structure, according to a review of the companies’ performance by The Wall Street Journal. Oh yeah and didn’t you report two years ago that tech companies would decline because of the Trump election - another chicken little story by the critics.
แหล่ง: WSJ - 🏆 98. / 63 อ่านเพิ่มเติม »
แหล่ง: BusinessInsider - 🏆 729. / 51 อ่านเพิ่มเติม »
แหล่ง: BusinessInsider - 🏆 729. / 51 อ่านเพิ่มเติม »
แหล่ง: Reuters - 🏆 2. / 97 อ่านเพิ่มเติม »